PMID- 38248799 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20240128 IS - 2075-4426 (Print) IS - 2075-4426 (Electronic) IS - 2075-4426 (Linking) VI - 14 IP - 1 DP - 2024 Jan 16 TI - Analysis of Thyroid Function in ANCA-Associated Vasculitis Patients with Renal Injury. LID - 10.3390/jpm14010099 [doi] LID - 99 AB - BACKGROUND: Previous studies indicated common thyroid dysfunction in various kidney diseases. This study aimed to investigate the thyroid function in patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV) with renal injury. METHODS: Briefly, 174 patients diagnosed as having AAV with renal injury and without previous thyroid disease history were included in the retrospective and prospective study. The clinical parameters were collected and compared between different groups. RESULTS: Of the patients included, 24 exhibited normal thyroid function, while 150 had thyroid dysfunction, including 55 (36.67%) with hypothyroidism. Those AAV patients with thyroid dysfunction showed different clinical parameters from those with normal thyroid function. The patients were followed up for a median of 68.6 (64.3; 72.8) months. Those with thyroid dysfunction were more prone to progressing to dialysis dependence compared to the group with normal thyroid function. Logistic regression analysis showed advanced age and decreased albumin as independent risk factors for thyroid dysfunction in patients with AAV. Survival analysis and multivariate Cox regression analysis showed that thyroid dysfunction was a risk factor for AAV patients with renal injury to progress to the endpoint of dialysis dependence. CONCLUSION: Thyroid dysfunction, predominantly hypothyroidism, was commonly complicated in AAV patients with renal injury. AAV patients with thyroid dysfunction were presented with different clinical parameters and more prone to progressing to dialysis dependence compared to those with normal thyroid function. FAU - Yu, Wenhui AU - Yu W AD - Department of Nephrology, Kidney Research Institute, West China Hospital of Sichuan University, Chengdu 610041, China. FAU - Wang, Yuelan AU - Wang Y AD - Renal Division, Department of Medicine, Chengdu Second People's Hospital, Chengdu 610041, China. FAU - Ma, Liang AU - Ma L AUID- ORCID: 0000-0001-8327-7969 AD - Department of Nephrology, Kidney Research Institute, West China Hospital of Sichuan University, Chengdu 610041, China. FAU - Gou, Shenju AU - Gou S AUID- ORCID: 0000-0002-0151-5036 AD - Department of Nephrology, Kidney Research Institute, West China Hospital of Sichuan University, Chengdu 610041, China. AD - Department of Nephrology, West China Tianfu Hospital of Sichuan University, Chengdu 610200, China. FAU - Fu, Ping AU - Fu P AD - Department of Nephrology, Kidney Research Institute, West China Hospital of Sichuan University, Chengdu 610041, China. LA - eng GR - Sichuan Science and Technology Program/Sichuan Science and Technology Program/ PT - Journal Article DEP - 20240116 PL - Switzerland TA - J Pers Med JT - Journal of personalized medicine JID - 101602269 PMC - PMC10817250 OTO - NOTNLM OT - antineutrophil cytoplasmic antibody OT - renal injury OT - thyroid dysfunction OT - vasculitis COIS- The authors declare no conflicts of interest. EDAT- 2024/01/22 06:43 MHDA- 2024/01/22 06:44 PMCR- 2024/01/16 CRDT- 2024/01/22 04:44 PHST- 2023/12/04 00:00 [received] PHST- 2024/01/08 00:00 [revised] PHST- 2024/01/12 00:00 [accepted] PHST- 2024/01/22 06:44 [medline] PHST- 2024/01/22 06:43 [pubmed] PHST- 2024/01/22 04:44 [entrez] PHST- 2024/01/16 00:00 [pmc-release] AID - jpm14010099 [pii] AID - jpm-14-00099 [pii] AID - 10.3390/jpm14010099 [doi] PST - epublish SO - J Pers Med. 2024 Jan 16;14(1):99. doi: 10.3390/jpm14010099.